哈罗制药 HROW
$26.89 +$0.85 (+3.26%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $26.80 -0.33%
开盘$26.40
昨收$26.04
当日区间$25.76 – $26.94
成交量650.9K
市值$1.01B
市盈率（TTM）–
股息率–
HROW 相关新闻
匹配 Harrow 或代码 HROW 的头条新闻，按最新排序。
- Leerink Partners Initiates Harrow(HROW.US) With Buy Rating, Announces Target Price $45
- Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
- Analysts Are Bullish on These NA Stocks: Harrow Health (HROW), Caris Life Sciences, Inc. (CAI) 正面
- BTIG Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $63
- Analysts' Top NA Picks: Harrow Health (HROW), Scribe Therapeutics Inc. (SCTX)
- Analysts Have Conflicting Sentiments on These NA Companies: Harrow Health (HROW) and Lineage, Inc. (LINE)
- H.C. Wainwright Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $70
- Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $88
- Analysts Are Bullish on These NA Stocks: Harrow Health (HROW), Amentum Holdings, Inc. (AMTM) 正面
- B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $60
- Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating, Announces Target Price $59
- H.C. Wainwright Remains a Buy on Harrow Health (HROW)
- B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $60 负面
- Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $88 负面
- Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Hims & Hers Health (HIMS) and ArriVent BioPharma, Inc. (AVBP)
暂无评论——快来第一个聊聊 HROW。
登录后参与讨论。